<DOC>
	<DOCNO>NCT01239472</DOCNO>
	<brief_summary>Currently , acute kidney injury diagnose increase serum creatinine . However , creatinine reliable marker acute change renal function . The biology renal graft influence chemokines reperfusion throughout course development interstitial fibrosis tubular atrophy ubiquitously present graft long-term survival . Moreover , evaluation change urinary cytokine may predict renal function acute rejection episodes response treatment . Today several study compare relative immunosuppression renal function , notice relationship cytokine chemokines . Thus , propose study inflammatory consequence blood urine early withdrawal calcineurin inhibitor ( ICN ) , renal biopsy renal transplant patient change immunosuppression 9 month .</brief_summary>
	<brief_title>Cytokines Evaluation Early Calcineurin Inhibitors Withdrawn Renal Transplant</brief_title>
	<detailed_description>1 . Research objectives OBJECTIVES Main Objectives : • Evaluate chemokines blood urine kidney transplant patient take prednisone , tacrolimus mycophenolate sodium compare use prednisone , mycophenolate sodium everolimus maintenance immunosuppression . Secondary Objectives : • Assess renal function ( serum creatinine clearance estimate Cockroft-Gault ) composite outcome ( acute rejection , graft loss , death abandonment study ) patient take prednisone , tacrolimus mycophenolate sodium compare take prednisone , mycophenolate sodium everolimus maintenance immunosuppression . 2 . Scientific background , relevance justification research In current clinical practice , acute kidney injury typically diagnose measure serum creatinine . Unfortunately , creatinine unreliable indicator acute change kidney function ( 1 ) . First , serum creatinine concentration may change 50 % kidney function already lose . Second , serum creatinine accurately depict kidney function steady state reach , may require several day . According Hu Knechtle ( 2 ) , chemokines influence least three aspect biology renal graft : 1 - restoration blood flow graft lead injury type ischemia / reperfusion chemokines recruit leukocytes ; 2 - receptor response infection immune suppression involve chemokines 3 - inflammatory component RA IF/TA control chemokines . Current data show urinary cytokine predict renal function month renal transplanted patient . In evaluation urinary cytokine chemokines presence acute rejection , take together study report elevation urinary level MIP-3α/CCL20 , IL-8/CXCL8 , IL-6 , TNF , IL10 , IFN , MCP-1 / CCL2 , IP10/CXCL10 , MIG/CXCL9 , I-TAC/CXCL11 , RANTES/CCL5 ( 2 , 3 , 4,5-10,11-13,14,15 ) . Only MIP-1β/CCL4 ( 4 ) urine increase , EGF decrease ( 5 ) . As predictor complication future change renal function , level TGF-β IP-10/CXCL10 associate renal function 6 month 4 year transplantation ( 16,17 ) . IP-10/CXCL10 , MIG/CXCL9 , CXCR3 , RANTES/CCL5 percentage bind IL-2 associated occurrence RA ( 6,13,18 ) . IP-10/CXCL10 MIG/CXCL9 also consider useful predictor response treatment RA ( 2,11,13 ) . Nankivell et al report 1year renal transplant , 94 % patient present chronic rejection grade I ( BANFF ) 76 % present calcineurin nephrotoxicity , although insufficient data urinary cytokine situation ( 19 ) . In recent study , Hu et al report urinary MIP-δ , OPG , IP-10/CXCL10 , MIG/CXCL9 good biomarkers acute renal rejection IF/TA ( 20 ) . Nowadays lot study compare immunosuppression relation renal function much relation chemokines cytokine , representative allograft inflammation fibrosis . So , suppose study inflammatory consequence early CNI withdraw renal transplant patient together renal biopsy immunosuppression modification 9 month .</detailed_description>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Calcineurin Inhibitors</mesh_term>
	<criteria>Patients 18 year 65 Recipients first kidney transplant Donor le 65 year PRA ( panel reactive antigen ) ≤ 30 % No acute rejection Proteinuria &lt; 1000 mg / multiple organ recipient recipient le 18 year Retransplant Recipients PRA &gt; 30 % Chronic liver failure Asymptomatic bacteriuria Creatinine ≥ 2 mg / dL time ICN withdrawal Proteinuria ≥ 1g/24h time ICN withdrawal Presence uncontrolled hypercholesterolemia ( ≥ 350 mg / dL , ≥ 9.1 mmol / L ) hypertriglyceridemia ( ≥ 500 mg / dL , ≥ 5.6 mmol / L )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>chronic allograft nephropathy</keyword>
	<keyword>cytokine</keyword>
	<keyword>kidney transplant</keyword>
	<keyword>calcineurin inhibitor withdraw</keyword>
</DOC>